FDA Approves Abuse Deterrent IR Oxycodone

The FDA has approved RoxyBond abuse-deterrent oxycodone hydrochloride tablets (RoxyBond, Inspirion) for the management of pain severe enough to require an opioid analgesic, and when alternative treatments are inadequate. The drug has multiple physical and chemical barriers that make it “more difficult and/or less rewarding” to abuse via intranasal or IV routes. For example, the drug creates a “viscous material that is difficult to syringe” when manipulated and subjected